O'Day Daniel Patrick
SEC CIK 1638643 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences | COB, CEO, Dir | 585.9K | — | $55.82M | 73 | 2022-01-26 | 2026-09-10 |
Most active insiders at GILD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Day Daniel Patrick | COB, CEO, Dir | — | $51.34M |
| 2 | Mercier Johanna | Chief Commercial Off | — | $18.52M |
| 3 | Telman Deborah H | EVP, GC, Corp. Affairs | — | $6.59M |
| 4 | Dickinson Andrew D | CFO | — | $4.68M |
| 5 | WELTERS ANTHONY | Dir | — | $2.68M |
| 6 | Bluestone Jeffrey | Dir | — | $1.97M |
| 7 | Kramer Kelly A. | Dir | — | $713.2K |
| 8 | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | — | — |
| 9 | Burkhart Erin | SVP, Controllership | — | — |
| 10 | Berger Dietmar | Chief Medical Off | — | — |
Transactions 73
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-11 18:27 | 2026-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +8,780 | 585.9K | +2% | — |
| D | 2026-09-11 18:27 | 2026-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $144.81 | -4,230 | 581.7K | -0.7% | -$612.5K |
| MT | 2026-09-02 16:12 | 2026-09-01 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $148.64 | -15.0K | 577.1K | -3% | -$2.23M |
| MT | 2026-08-04 17:40 | 2026-08-03 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $130.31 | -15.0K | 592.1K | -2% | -$1.95M |
| MT | 2026-07-02 16:14 | 2026-07-01 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $126.29 | -15.0K | 607.1K | -2% | -$1.89M |
| D | 2026-06-11 18:29 | 2026-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +8,779 | 626.3K | +1% | — |
| D | 2026-06-11 18:29 | 2026-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $121.48 | -4,213 | 622.1K | -0.7% | -$511.8K |
| MT | 2026-06-02 18:04 | 2026-06-01 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $131.46 | -15.0K | 617.6K | -2% | -$1.97M |
| MT | 2026-04-29 17:53 | 2026-04-28 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $129.16 | -10.0K | 632.6K | -2% | -$1.29M |
| 2026-03-30 | 2026-03-27 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $136.82 | -10.0K | 642.6K | -2% | -$1.37M | |
| D | 2026-03-12 | 2026-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +20.0K | 662.3K | +3% | — |
| D | 2026-03-12 | 2026-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $148.56 | -9,767 | 652.6K | -1% | -$1.45M |
| 2026-03-02 | 2026-02-27 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | A - Grant | $0.00 | +38.4K | 652.3K | +6% | $0 | |
| M | 2026-03-02 | 2026-02-27 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $144.79 | -10.0K | 642.3K | -2% | -$1.45M |
| D | 2026-02-06 | 2026-02-05 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | $66.01 | +115.6K | 729.6K | +19% | +$7.63M |
| D | 2026-02-06 | 2026-02-05 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale+OE | $150.00 | -115.6K | 613.9K | -16% | -$17.35M |
| 2026-02-05 | 2026-02-03 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $143.28 | -74.5K | 613.9K | -11% | -$10.67M | |
| 2026-02-05 | 2026-02-03 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | A - Grant | $0.00 | +131.7K | 688.4K | +24% | $0 | |
| M | 2026-01-29 | 2026-01-28 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $139.89 | -10.0K | 561.7K | -2% | -$1.40M |
| D | 2026-01-26 | 2026-01-23 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | $66.01 | +115.6K | 682.3K | +20% | +$7.63M |
| D | 2026-01-26 | 2026-01-23 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale+OE | $135.00 | -115.6K | 566.7K | -17% | -$15.61M |
| 2025-12-30 | 2025-12-29 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $124.83 | -10.0K | 566.7K | -2% | -$1.25M | |
| D | 2025-12-11 | 2025-12-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $121.34 | -4,931 | 576.7K | -0.8% | -$598.3K |
| D | 2025-12-11 | 2025-12-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +10.4K | 581.6K | +2% | — |
| M | 2025-12-01 | 2025-11-28 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $126.54 | -10.0K | 578.0K | -2% | -$1.27M |
| M | 2025-10-29 | 2025-10-28 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $119.39 | -10.0K | 583.2K | -2% | -$1.19M |
| M | 2025-09-30 | 2025-09-29 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $111.66 | -10.0K | 591.2K | -2% | -$1.12M |
| D | 2025-09-11 | 2025-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +10.4K | 606.2K | +2% | — |
| D | 2025-09-11 | 2025-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $115.25 | -4,949 | 601.2K | -0.8% | -$570.4K |
| 2025-08-29 | 2025-08-28 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $113.63 | -10.0K | 595.7K | -2% | -$1.14M | |
| M | 2025-07-29 | 2025-07-28 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $113.94 | -10.0K | 614.1K | -2% | -$1.14M |
| M | 2025-07-01 | 2025-06-30 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $110.44 | -10.0K | 616.3K | -2% | -$1.10M |
| D | 2025-06-11 | 2025-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $110.09 | -4,968 | 625.7K | -0.8% | -$546.9K |
| D | 2025-06-11 | 2025-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +10.4K | 630.7K | +2% | — |
| M | 2025-06-02 | 2025-05-30 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $110.41 | -10.0K | 623.9K | -2% | -$1.10M |
| D | 2025-03-12 | 2025-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +24.0K | 641.9K | +4% | — |
| D | 2025-03-12 | 2025-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $117.21 | -11.6K | 630.3K | -2% | -$1.36M |
| M | 2025-02-06 | 2025-02-04 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | A - Grant | $0.00 | +224.5K | 726.0K | +45% | $0 |
| 2025-02-06 | 2025-02-04 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $97.99 | -108.2K | 617.9K | -15% | -$10.60M | |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +10.3K | 506.3K | +2% | — |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $92.34 | -4,762 | 501.5K | -0.9% | -$439.7K |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +10.3K | 500.7K | +2% | — |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $81.44 | -4,749 | 496.0K | -0.9% | -$386.8K |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +10.3K | 495.1K | +2% | — |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $65.25 | -4,693 | 490.4K | -0.9% | -$306.2K |
| D | 2024-03-11 | 2024-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $75.12 | -13.8K | 484.8K | -3% | -$1.04M |
| DM | 2024-03-11 | 2024-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +29.9K | 498.6K | +6% | — |
| 2024-02-02 | 2024-01-31 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $78.26 | -79.3K | 468.7K | -14% | -$6.21M | |
| M | 2024-02-02 | 2024-01-31 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | A - Grant | $0.00 | +230.7K | 368.1K | +168% | $0 |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $79.02 | -3,341 | 387.7K | -0.9% | -$264.0K |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +7,347 | 391.0K | +2% | — |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +7,348 | 387.1K | +2% | — |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $76.00 | -3,366 | 383.7K | -0.9% | -$255.8K |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +7,346 | 269.5K | +3% | — |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $78.12 | -3,409 | 266.1K | -1% | -$266.3K |
| DM | 2023-03-14 | 2023-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +30.3K | 379.0K | +9% | — |
| D | 2023-03-14 | 2023-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $79.50 | -14.0K | 375.8K | -4% | -$1.11M |
| D | 2023-03-02 | 2023-03-01 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $79.59 | -4,842 | 359.5K | -1% | -$385.4K |
| D | 2023-03-02 | 2023-03-01 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +11.4K | 364.3K | +3% | — |
| 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $84.02 | -59.1K | 353.0K | -14% | -$4.96M | |
| M | 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | A - Grant | $0.00 | +215.0K | 275.4K | +356% | $0 |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $87.97 | -1,542 | 254.6K | -0.6% | -$135.6K |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +3,300 | 256.2K | +1% | — |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $65.28 | -1,528 | 252.9K | -0.6% | -$99.7K |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +3,301 | 254.4K | +1% | — |
| D | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $60.74 | -1,539 | 251.1K | -0.6% | -$93.5K |
| D | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +3,300 | 252.6K | +1% | — |
| DM | 2022-03-14 | 2022-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | $0.00 | +24.0K | 260.4K | +10% | $0 |
| D | 2022-03-14 | 2022-03-10 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $57.92 | -11.1K | 249.3K | -4% | -$640.1K |
| DM | 2022-03-03 | 2022-03-01 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +54.3K | 259.6K | +26% | — |
| D | 2022-03-03 | 2022-03-01 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $60.26 | -23.2K | 236.4K | -9% | -$1.40M |
| 2022-01-28 | 2022-01-26 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $67.34 | -33.8K | 205.4K | -14% | -$2.28M | |
| M | 2022-01-28 | 2022-01-26 | GILD | Gilead Sciences | O'Day Daniel Patrick | COB, CEO, Dir | A - Grant | $0.00 | +146.7K | 156.5K | +1,491% | $0 |
Purchase Sale Sale after option exercise All abbreviations